EX-23.1 3 brhc10035646_ex23-1.htm EXHIBIT 23.1
Exhibit 23.1


Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement (No. 333-251105) on Form S-8 and in the registration statement (No. 333-261970) on Form S-3 of our report dated March 28, 2022, with respect to the consolidated financial statements of Kinnate Biopharma Inc.
/s/ KPMG LLP
San Diego, California
March 28, 2022